Furthermore, targeting Rab27a or TRAF3IP2 each reduced the potential of the tumor cells with the surrounding stroma, indicated by reduced growth of MSCs coinjected with MDAKDRab27a. The gene discussed is TRAF3IP2; the disease is neoplasm.